Related Experiment Video
Updated: May 22, 2026
02:09
Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
Published on: April 12, 2024
Biomarkers in obstructive respiratory diseases: an update
F Braido1, D Bagnasco, N Scichilone
1Allergy and Respiratory Diseases Clinic, DIMI, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy. fulvio.braido@unige.it
Panminerva Medica
|April 25, 2012
Summary
Identifying new biomarkers for chronic obstructive pulmonary disease (COPD) is crucial. The ECLIPSE study found 15 increased biomarkers, with CC-16 and SPD showing promise for personalized COPD management.
Area of Science:
- Pulmonary Medicine
- Biomarker Discovery
- Inflammation Research
Background:
- Chronic obstructive pulmonary disease (COPD) involves chronic airway inflammation with potential systemic effects.
- Current diagnostic and prognostic tools for COPD are insufficient, highlighting the need for novel biomarkers.
- Comorbidities and aging (inflammaging) complicate biomarker interpretation in COPD.
Purpose of the Study:
- To identify reliable biomarkers for early COPD detection, diagnosis, and personalized treatment strategies.
- To explore biomarkers correlating with COPD subtypes and disease progression.
- To evaluate the potential of novel biomarkers in managing COPD patients.
Main Methods:
- The ECLIPSE study evaluated thirty-four potential biomarkers in individuals with COPD.
- Statistical analysis was used to identify biomarkers elevated in COPD patients compared to controls.
- Specific lung proteins like CC-16 and SPD were investigated for their clinical relevance.
Main Results:
- Fifteen of the thirty-four evaluated biomarkers were found to be increased in COPD patients.
- CC-16 and SPD demonstrated potential for detecting lung damage, predicting exacerbations, and guiding treatment response.
- No single biomarker currently meets all requirements for comprehensive COPD management.
Conclusions:
- A combination of novel biomarkers alongside existing tools is necessary for optimizing COPD patient care.
- Biomarkers like CC-16 and SPD offer promising avenues for improving COPD diagnosis and treatment selection.
- Further research is needed to validate and integrate these biomarkers into clinical practice for COPD.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:27Physical Assessment of the Respiratory Tract II: Inspection
Physical assessment of the respiratory tract through inspection is a crucial step in understanding the patient's respiratory health. It provides insights into the functioning of the respiratory system, the musculoskeletal structure, and even the patient's nutritional status. This comprehensive approach involves observing several vital aspects: chest configuration, breathing patterns, respiratory rates, skin color, and use of accessory muscles.
Chest Configuration
The chest configuration can...
Chest Configuration
The chest configuration can...
01:19Respiratory Assessment: Purpose and Indications
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation